title: Beyond antidoping and harm minimisation: a stakeholder-corporate social responsibility approach to drug control for sport.
abstract: Debate about the ethics of drug control in sport has largely focused on arguing the relative merits of the existing antidoping policy or the adoption of a health-based harm minimisation approach. A number of ethical challenges arising from antidoping have been identified, and a number of, as yet, unanswered questions remain for the maturing ethics of applying harm minimisation principles to drug control for sport. This paper introduces a 'third approach' to the debate, examining some implications of applying a stakeholder theory of corporate social responsibility (CSR) to the issue of doping in sport. The introduction of the stakeholder-CSR model creates an opportunity to challenge the two dominant schools by enabling a different perspective to contribute to the development of an ethically robust drug control for sport.
authors.forename: Jason
authors.initials: J
authors.lastname: Mazanov
mesh_terms: D056352:Athletes; D004300:Doping in Sports / Q000941:ethics / Q000639:trends; D004335:Drug and Narcotic Control / Q000639:trends; D040261:Harm Reduction / Q000941:ethics; D006801:Humans; D012941:Social Responsibility; D013177:Sports / Q000941:ethics*
keywords: Occupational Health; Substance Abusers/Users of Controlled Substances